News + Updates
GHO realises investment in BioAgilytix to Cinven
GHO Capital acquires Genesis Research, a pioneer in tech-enabled Real-World Evidence and HEOR services
GHO appoints Manuela Rankine as Director of Sustainable Investing
X-Chem acquires Glamorous AI and ComInnex, harnessing machine learning to accelerate outcomes across small molecule drug discovery
GHO Capital invests in Sanner Group, a leading global supplier of high-quality active packaging solutions and components for the Pharmaceutical, Diagnostic, Nutraceutical and MedTech industries
Velocity Clinical Research’s multi-site acquisitions signal new frontier for clinical site management industry
Ardena acquires Idifarma from Suanfarma and Sodena, adding spray drying technology and high potency capabilities
GHO Capital invests in ClearView Healthcare Partners, the leading provider of strategic consulting services to global innovators in the life sciences
BioAgilytix to acquire Australia-based 360biolabs® and US-based MicroConstants, to advance its global expansion
Velocity Clinical Research strengthens management team amid European expansion
GHO Capital announces final close of Fund III with over €2 billion of capital to invest
Load more